SITC Archive Library

iSBTc 25th Annual Meeting Workshop 

02-27-2018 09:24

The International Society for Biological Therapy of Cancer (iSBTc) 25th Annual Meeting: Workshop on Monoclonal Antibodies in Cancer
October 1, 2010
Hyatt Regency Washington on Capital Hill
Washington, D.C.

Program Organizers
Glenn Dranoff, MD - Dana-Farber Cancer Institute
Ira Mellman, PhD - Genetech, Inc.
George J. Weiner, MD - University of Iowa

Program Summary
To ensure effective translation of monoclonal antibody-based cancer immunotherapies to the clinical arena - either as monotherapies or in combination with other cancer therapies - it is critical that clinicians and scientists are educated on the most current information about engineering monoclonal antibodies, immunomodulatory monoclonal antibodies, tumor-targeting monoclonal antibodies, investigation of monoclonal antibodies as vaccines, and the lessons learned from monoclonal antibody therapy in other diseases. Therefore, this Workshop strives to improve the clinical outcomes of cancer patients through the development and clinical application of antibody-based cancer treatments.

Target Audience
The target audience for these programs incorporates basic and clinical investigators from academic, regulatory and biopharmaceutical venues. The audience includes clinicians, researchers, students, post-doctoral fellows and allied health professionals.

Presentations and video recordings are available based on permission from presenters.


#ClinicalTrials #BrainCancers #BreastCancers #GastrointestinalCancers #LungCancers #Neuroblastoma #PresentationSlides #AnnualMeeting #Cytokines #TherapeuticAntibodies #Vaccines #AlliedHealth #Clinician #Industry #Oncologist #Researcher #2010 #HeadandNeckCancers #Leukemia #Lymphoma #Melanoma #Non-SmallCellLungCancer #BladderCancer #CombinationTherapy

Statistics
0 Favorited
11 Views
7 Files
0 Shares
19 Downloads
Attachment(s)
pdf file
Workshop Welcome and Overview   34 KB   1 version
Uploaded - 02-27-2018
Meeting: iSBTc 25th Annual Meeting Workshop; Presentation: Workshop Welcome and Overview; Presenter: George J. Weiner, MD - University of Iowa; Date: Friday, October 1, 2010
pdf file
Antibody-Based Cancer Immunotherapy   1.34 MB   1 version
Uploaded - 02-27-2018
Meeting: iSBTc 25th Annual Meeting Workshop; Session 1: Tumor Targeted Antibodies; Presentation: Antibody-Based Cancer Immunotherapy; Presenter: Louis M. Weiner, MD - Georgetown University Medical Center; Date: Friday, October 1, 2010
pdf file
Combining Tumor Reactive mAbs with Cytokines to Induce AD...   1.48 MB   1 version
Uploaded - 02-27-2018
Meeting: iSBTc 25th Annual Meeting Workshop; Session 1: Tumor Targeted Antibodies; Presentation: Combining Tumor Reactive mAbs with Cytokines to Induce ADCC in Patients; Presenter: Paul M. Sondel, MD, PhD - University of Wisconsin; Date: Friday, October 1, 2010
pdf file
Antibody-Targeted Vaccines   1.36 MB   1 version
Uploaded - 02-27-2018
Meeting: iSBTc 25th Annual Meeting Workshop; Session 3: Investigating Antibodies as "Vaccines"; Presentation: Antibody-Targeted Vaccines; Presenter: Tibor Keler, PhD - Celldex Therapeutics, Inc.; Date: Friday, October 1, 2010
pdf file
Two-in-One Antibody - From Proof-of-Concept to Therapeuti...   1.38 MB   1 version
Uploaded - 02-27-2018
Meeting: iSBTc 25th Annual Meeting Workshop; Session 4: Antibody Engineering; Presentation: Two-in-One Antibody - From Proof-of-Concept to Therapeutic Candidate; Presenter: Germaine Fuh, PhD - Genentech, Inc.; Date: Friday, October 1, 2010
pdf file
Engineered Anti-Cancer Antibodies with Enhanced Effector ...   1.62 MB   1 version
Uploaded - 02-27-2018
Meeting: iSBTc 25th Annual Meeting Workshop; Session 4: Antibody Engineering; Presentation: Engineered Anti-Cancer Antibodies with Enhanced Effector Functions; Presenter: Pablo Umaña, PhD - Roche Glycart AG; Date: Friday, October 1, 2010
pdf file
T Cell Engineering BiTE Antibodies for Cancer Therapy   538 KB   1 version
Uploaded - 02-27-2018
Meeting: iSBTc 25th Annual Meeting Workshop; Session 4: Antibody Engineering; Presentation: T Cell Engineering BiTE Antibodies for Cancer Therapy; Presenter: Patrick Baeuerle, PhD - Micromet, Inc.; Date: Friday, October 1, 2010